INC Research is a therapeutically focused global clinical research organization (CRO) providing a complete range of Phase I – Phase IV clinical development services for the world’s biopharmaceutical companies

In July 2011, INC Research acquired Kendle International, a leading global CRO, to create a new enviable force in global drug development outsourcing. With the addition of Kendle, INC Research is now better positioned to participate in evolving drug development outsourcing models that require broader capabilities and critical mass. The new company is also in a stronger position to drive overall quality and efficiency improvements through more innovative and forward-thinking outsourcing approaches.